Aclaris Therapeutics, Inc. · NASDAQ:ACRS

Frazier Life Sciences Public Fund, L.P. reported a 5.40% stake in Aclaris Therapeutics, Inc. (Schedule 13G)

Event Sep 14, 2026 · Filed Sep 21, 2026

Frazier Life Sciences Public Fund, L.P. reported a 5.40% stake in Aclaris Therapeutics, Inc., 7,879,943 shares, as a passive investor on Sep 14, 2026. Filed Sep 21, 2026 (Schedule 13G).

Stake
5.40%
Shares
7,879,943
Intent
Passive
What changed
Crossed above 5%
Filed together
9 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.5.40%7,879,943
FHMLSP, L.P.5.40%7,879,943
FHMLSP, L.L.C.5.40%7,879,943
Frazier Life Sciences XI, L.P.0.10%86,910
FHMLS XI, L.P.0.10%86,910
FHMLS XI, L.L.C.0.10%86,910
Frazier Life Sciences XII, L.P.0.50%762,663
FHMLS XII, L.P.0.50%762,663
FHMLS XII, L.L.C.0.50%762,663

Source

View original at SEC

Related